Gang Liu

Gang (Gavin) Liu is an accomplished professional in the field of cell therapy and biotechnology, currently serving as QC Director at uBriGene Biosciences Inc. since September 2024. With extensive experience, Liu previously held roles such as Head of Manufacturing & Tech Op/CMC at AffyImmune Therapeutics, where responsibilities included leading CAR T cell product manufacturing and overseeing CMC logistics. Prior to that, Liu was Associate Director/Principal Scientist at Simcere Pharmaceutical Group, focusing on CARNK allogenic product pipeline development. A background in process development at Mustang Bio contributed to expertise in CAR T and stem cell gene therapy. Liu's early career included a significant research scientist role at the University of Washington, leading studies in prostate cancer, coupled with advanced training, including a postdoctoral fellowship at the University of California, San Francisco, and a Ph.D. in Surgery from Peking University.